» Articles » PMID: 8202524

Alterations in Major Histocompatibility Complex Association of Myocarditis Induced by Coxsackievirus B3 Mutants Selected with Monoclonal Antibodies to Group A Streptococci

Overview
Specialty Science
Date 1994 Jun 7
PMID 8202524
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Three monoclonal antibodies (mAbs), 49.8.9, 36.2.2, and 54.2.8, made to the group A streptococcus M5 serotype identify crossreactive epitopes in cardiac tissues and also neutralize a highly myocarditic variant of coxsackievirus B3 (H3). Mutants of H3 were selected with these mAbs and evaluated for pathogenicity compared with the wild-type virus. H3 and the mutant variants selected with mAbs 36.2.2 (H3-36) and 54.2.8 (H3-54) induced severe myocarditis in DBA/2 (H-2d) and A/J (H-2a) male mice, whereas CBA (H-2k) mice were disease resistant. The virus variant isolated with mAb 49.8.9 (H3-49) was strikingly different and caused disease in CBA and A/J mice but not in DBA/2 animals, suggesting that the major histocompatibility complex association of the disease had been altered. This hypothesis was confirmed by using B10 congenic mice. In addition, T lymphocytes from the H3 and H3-49 virus-infected mice responded to distinctly different peptides in the streptococcal M protein, suggesting that certain epitopes of infectious agents which are shared with host tissues may be critical in determining disease susceptibility in genetically distinct individuals.

Citing Articles

T-Cell Receptor Sequences Identify Combined Coxsackievirus- Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus- Infections for Type 1 Diabetes.

Root-Bernstein R Int J Mol Sci. 2024; 25(3).

PMID: 38339075 PMC: 10855694. DOI: 10.3390/ijms25031797.


Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches.

Huang S, Zhang C, Li J, Dai Z, Huang J, Deng F Front Immunol. 2022; 13:933594.

PMID: 36439191 PMC: 9682020. DOI: 10.3389/fimmu.2022.933594.


Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Moslehi J, Lichtman A, Sharpe A, Galluzzi L, Kitsis R J Clin Invest. 2021; 131(5).

PMID: 33645548 PMC: 7919710. DOI: 10.1172/JCI145186.


Triggers of Inflammatory Heart Disease.

Lasrado N, Yalaka B, Reddy J Front Cell Dev Biol. 2020; 8:192.

PMID: 32266270 PMC: 7105865. DOI: 10.3389/fcell.2020.00192.


Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Cunningham M Microbiol Spectr. 2019; 7(4).

PMID: 31373269 PMC: 6684244. DOI: 10.1128/microbiolspec.GPP3-0045-2018.


References
1.
Blay R, Simpson K, Leslie K, Huber S . Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice. Am J Pathol. 1989; 135(5):899-907. PMC: 1880102. View

2.
Weller A, Simpson K, Herzum M, Van Houten N, Huber S . Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis. J Immunol. 1989; 143(6):1843-50. View

3.
Yamada M, Zurbriggen A, Fujinami R . Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med. 1990; 171(6):1893-907. PMC: 2187947. DOI: 10.1084/jem.171.6.1893. View

4.
Huber S, Haisch C, Lodge P . Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J Virol. 1990; 64(9):4516-22. PMC: 247922. DOI: 10.1128/JVI.64.9.4516-4522.1990. View

5.
Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel R . Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 1990; 346(6285):629-33. DOI: 10.1038/346629a0. View